NDC11 16571069401
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 16571-0694-01 | 16571-0694 |
| 16571-0694-1 | 16571-0694 |
| 16571-694-01 | 16571-694 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2f8e82d7-6baf-456a-b8c3-4fda6e317902 | 2026-04-08 | Warnings, Adverse reactions | 16571-694-01 16571-694 16571069401 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.